What is the financial condition of CRYO-CELL?
CRYO-CELL is an established, successful and profitable corporation, and has provided stem cell banking to more families than any other company. We have been offering this service since 1992-longer than any other company. CRYO-CELL is a publicly traded company (OTC BB: Symbol . CCEL). Our financial information is available on the Internet and filed with the SEC. In addition to our cell banking business, CRYO-CELL has an equity position in Saneron CCEL Therapeutics, Inc., which has an agreement with the University of South Florida at Tampa for their research in treating neurologic degenerative diseases. CRYO-CELL has been granted the world marketing rights to any products developed as a result of this agreement.